Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125931363 | 12593136 | 3 | F | 20160110 | 20160907 | 20160726 | 20160919 | EXP | IT-MINISAL02-367337 | IT-MYLANLABS-2016M1029810 | MYLAN | 0.00 | Y | 0.00000 | 20160919 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125931363 | 12593136 | 1 | PS | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG, QD | U | U | 90970 | 40 | MG | TABLET | QD | ||||
| 125931363 | 12593136 | 2 | SS | TRIPLIAM | AMLODIPINEINDAPAMIDEPERINDOPRIL | 1 | Oral | 17.5 MG, QD | U | U | 0 | 17.5 | MG | TABLET | QD | ||||
| 125931363 | 12593136 | 3 | SS | TRIATEC /00885601/ | RAMIPRIL | 1 | Oral | 5 MG, QD | 1875 | MG | Y | U | 0 | 5 | MG | TABLET | QD | ||
| 125931363 | 12593136 | 4 | C | NORVASC | AMLODIPINE BESYLATE | 1 | UNK | D | 0 | ||||||||||
| 125931363 | 12593136 | 5 | C | ASCRIPTIN | ASPIRIN | 1 | UNK | D | 0 | ||||||||||
| 125931363 | 12593136 | 6 | C | NORMIX | RIFAXIMIN | 1 | D | 0 | |||||||||||
| 125931363 | 12593136 | 7 | C | CLEXANE | ENOXAPARIN SODIUM | 1 | D | 0 | |||||||||||
| 125931363 | 12593136 | 8 | C | LENTO KALIUM | POTASSIUM CHLORIDE | 1 | D | 0 | |||||||||||
| 125931363 | 12593136 | 9 | C | ATORVASTATINA | ATORVASTATIN | 1 | D | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125931363 | 12593136 | 1 | Antacid therapy |
| 125931363 | 12593136 | 2 | Essential hypertension |
| 125931363 | 12593136 | 3 | Essential hypertension |
| 125931363 | 12593136 | 4 | Product used for unknown indication |
| 125931363 | 12593136 | 5 | Product used for unknown indication |
| 125931363 | 12593136 | 6 | Product used for unknown indication |
| 125931363 | 12593136 | 7 | Product used for unknown indication |
| 125931363 | 12593136 | 8 | Product used for unknown indication |
| 125931363 | 12593136 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125931363 | 12593136 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125931363 | 12593136 | Confusional state | |
| 125931363 | 12593136 | Diarrhoea | |
| 125931363 | 12593136 | Dyspepsia | |
| 125931363 | 12593136 | Hypokalaemia | |
| 125931363 | 12593136 | Nausea | |
| 125931363 | 12593136 | Vomiting | |
| 125931363 | 12593136 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125931363 | 12593136 | 1 | 20150101 | 0 | ||
| 125931363 | 12593136 | 2 | 20150101 | 0 | ||
| 125931363 | 12593136 | 3 | 20150101 | 20160110 | 0 |